Şanlıurfa İlindeki Primer Enürezis Nokturna Şikâyeti ile Gelen Hastaların Değerlendirilmesi

Objective: Evaluation of our primary nocturnal enuresis patients’ profile and their treatment outcome. Material and Methods: We included 324 of the 540 patients aged over 5 years who had applied to our outpatients between January 2013 and January 2016 and were treated for primary nocturnal enuresis. Fifty-six patients who had not received relevant information before were treated for one month with behavioral and motivational therapy. A total of 324 patients who did not benefit from this behavioral and motivational therapy or who showed relapse were started on desmopressin at a dose of 60-120 micrograms. “Full response” was defined as a decrease of 90-100% in the number of wetting instances, “moderate response” as a decrease of 50-90%, and “failed response” as a decrease of less than 50%. Treatment and relapse rates were evaluated based on the response to therapy at the time of follow-up. Results: The mean age was 10.57±2.37 (minimum 5 maximum 18) years, except the 8 patients who were treated with behavioral and motivational therapy and had no relapse. Full dryness was provided in 166 (51.2%) of the patients who did not have benefit from the behavioral and motivational therapy by itself and used 120 micrograms Desmopressin. “Moderate response” was obtained in 107 (33.3%) patients. “Failed response” was obtained in 51 (15.5%) patients. Relapse was seen in case of discontinuing Desmopressin in 45 (27.1%) patients who had benefited from Desmopressin. Treatment could not proceed in 4 patients who did not respond because of headache and allergy. Conclusion: Due to the specific location of our hospital, we observed that the patients’ age of presentation to the hospital was higher. The first step in the treatment phase, which consists of informing the patient and behavioral and motivational therapy, therefore did not satisfy many of the relatives of the patient. A combination with medical treatment was mostly used because of the high expectation of success from the therapy. We believe that the causes of the lower than usual medical treatment success rate were the difficulties with treatment compliance and uninformed drug usage.